Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression
Open Access
- 1 May 2009
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 22 (8), 1083-1093
- https://doi.org/10.1038/modpathol.2009.69
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Characterization of TMPRSS2-ERG Fusion High-Grade Prostatic Intraepithelial Neoplasia and Potential Clinical ImplicationsClinical Cancer Research, 2008
- TMPRSS2:ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable PrognosisClinical Cancer Research, 2008
- Characterization of TMPRSS2-ETS Gene Aberrations in Androgen-Independent Metastatic Prostate CancerCancer Research, 2008
- Two Unique Novel Prostate-Specific and Androgen-Regulated Fusion Partners of ETV4 in Prostate CancerCancer Research, 2008
- A causal role for ERG in neoplastic transformation of prostate epitheliumProceedings of the National Academy of Sciences, 2008
- Role of the TMPRSS2-ERG Gene Fusion in Prostate CancerNeoplasia, 2008
- Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 Gene Fusions in Prostate CancerCancer Research, 2008
- Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancersJournal of Clinical Pathology, 2007
- Heterogeneity of TMPRSS2 Gene Rearrangements in Multifocal Prostate Adenocarcinoma: Molecular Evidence for an Independent Group of DiseasesCancer Research, 2007
- FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcomeBritish Journal of Cancer, 2007